โ† All Topics / eu

EU 2020 354 entry 21 acute intestinal

EU_2020_354_entry_21_acute_intestinal

eu 221 tok en 2026-07-18

EU Reg 2020/354 Part B Entry 21 โ€” Reduction of acute intestinal absorptive disorders

Species: Dogs and cats

Purpose (essential nutritional characteristics): Reduction of acute intestinal absorptive disorders โ€” Increased level of electrolytes: โ€” Sodium โ‰ฅ 1,8 % โ€” Potassium โ‰ฅ 0,6 % And Highly digestible carbohydrates: โ€” โ‰ฅ 32 %

Duration of use: 1 โ€“ 7 days

Source: EU Reg 2020/354 Part B (consolidated text per EUR-Lex CELEX:02020R0354, version 2025-04-22). Entry 21 is part of the 44 PARNUT entries in Part B (range 10-72). Cross-references: AAFCO nutrition profiles for chronic kidney disease, cardiac disease, dermatological conditions. FEDIAF nutritional guidelines 2025 provide complementary guidance but do not authorize therapeutic claims โ€” EU 2020/354 is required for products marketed with PARNUT claims.

Notes: This entry is part of the 44-entry block (10-30 + 50-72). Entries 31-49 are not used in the current consolidated text (numbering jumps from 30 to 50). Always consult official EUR-Lex consolidated 2020/354 text when preparing EU-market petitions for products covered by Entry 21.

Sources

  • reg_2020_354_consolidated_20250422.txt